Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-19-011907
Filing Date
2019-05-22
Accepted
2019-05-22 21:26:54
Documents
3
Period of Report
2019-05-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 6505
2 POWER OF ATTORNEY poa_canaanx.htm EX-24.1 17416
3 JOINT FILER INFORMATION ex99.htm EX-99 6693
  Complete submission text file 0001567619-19-011907.txt   32801
Mailing Address 285 RIVERSIDE AVE. SUITE 250 WESTPORT CT 06880
Business Address 285 RIVERSIDE AVE. SUITE 250 WESTPORT CT 06880 203-855-0400
CANAAN X L.P. (Reporting) CIK: 0001619859 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38915 | Film No.: 19847716

Mailing Address 2765 SAND HILL ROAD MENLO PARK CA 94025
Business Address 2765 SAND HILL ROAD MENLO PARK CA 94025 6508548092
Canaan Partners X LLC (Reporting) CIK: 0001673228 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38915 | Film No.: 19847717

Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Issuer) CIK: 0001676725 (see all company filings)

EIN.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations